Clinical trial
N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
NCT00332605 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00332605 |
|---|---|
| Title | N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence |
| Official title | A Double-Blind Study of N-Acetyl Cysteine Plus Naltrexone in the Treatment of Methamphetamine Dependence |
| Lead sponsor | University of Chicago, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Methamphetamine Dependence |
| Intervention type | Drug |
| Interventions | Naltrexone plus N-Acetyl Cysteine, Placebo |
| Enrollment | 45 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Jun 1, 2006 |
| Last update posted | Aug 23, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: